TRIPLE ANTIBIOTIC- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment Egyesült Államok - angol - NLM (National Library of Medicine)

triple antibiotic- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment

phoenix pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment Egyesült Államok - angol - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

e. fougera & co., a division of nycomed us inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 in 1 g - bacitracin zinc and polymyxin b sulfate ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. bacitracin zinc and polymyxin b sulfate ophthalmic ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

GEN-CEE PLUS Capsule Fülöp-szigetek - angol - FDA (Food And Drug Administration)

gen-cee plus capsule

jralph pharmaceuticals, inc. - ascorbic acid (as sodium ascorbate) , zinc - capsule - 562.50mg (equiv. to 500mg ascorbic acid)/ 32.93mg (equiv. to 12mg elemental zinc)

Hiberix powder & diluent for sol for inj; Haemophilus influenzae type b (Hib) conjugated vaccine Málta - angol - Malta Medicines Authority

hiberix powder & diluent for sol for inj; haemophilus influenzae type b (hib) conjugated vaccine

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - haemophilus influenzae, b, tetanus toxoid - powder and solvent for solution for infusion - haemophilus influenzae b 10 µg tetanus toxoid 25 µg - vaccines

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment Egyesült Államok - angol - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

ZEPZELCA- lurbinectedin injection, powder, lyophilized, for solution Egyesült Államok - angol - NLM (National Library of Medicine)

zepzelca- lurbinectedin injection, powder, lyophilized, for solution

jazz pharmaceuticals, inc. - lurbinectedin (unii: 2cn60tn6zs) (lurbinectedin - unii:2cn60tn6zs) - zepzelca is indicated for the treatment of adult patients with metastatic small cell lung cancer (sclc) with disease progression on or after platinum-based chemotherapy. this indication is approved under accelerated approval based on overall response rate and duration of response [see clinical studies (14) ] . continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). none. risk summary based on animal data and its mechanism of action [see clinical pharmacology (12.1)] , zepzelca can cause fetal harm when administered to a pregnant woman. there are no available data to inform the risk of zepzelca use in pregnant women. intravenous administration of a single lurbinectedin dose (approximately 0.2 times the 3.2 mg/m2 clinical dose) to pregnant rats during the period of organogenesis caused embryolethality (see data) . advise pregnant women of the potential risk to a fetus. the estimated background risk of major birth defects and mi

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment Egyesült Államok - angol - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

rpk pharmaceuticals, inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Cixtor-Z Syrup Fülöp-szigetek - angol - FDA (Food And Drug Administration)

cixtor-z syrup

solvang pharmaceuticals, inc. - ascorbic acid , zinc - syrup - 100 mg/10 mg (equivalent to 27.45mg zinc sulfate monohydrate ) per 5ml syrup

Enhancee Capsule Fülöp-szigetek - angol - FDA (Food And Drug Administration)

enhancee capsule

aldril pharmaceutical inc. - ascorbic acid , zinc - capsule - 500 mg (equivalent to 532.43 mg sodium ascorbate /10 mg (equivalent to 70 mg zinc gluconate) capsule

Ascorb Z+ Capsule Fülöp-szigetek - angol - FDA (Food And Drug Administration)

ascorb z+ capsule

westfield pharmaceuticals, inc. - ascorbic acid , zinc - capsule - 500 mg (equivalent to 562.43 mg sodium ascorbate)/ 10 mg (equivalent to 70 mg zinc gluconate)